Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in CorMedix Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
86
+21 vs. Q1 2023
Shares held
19.2M
+8.44M (+78.6%) vs. Q1 2023
Total value
$76.1M
+$31.5M (+70.5%) vs. Q1 2023
New holders
35
23 more added
Sold out
14
12 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 86 institutions
Q1 2021: 79 institutionsQ2 2021: 79 institutionsQ3 2021: 79 institutionsQ4 2021: 80 institutionsQ1 2022: 85 institutionsQ2 2022: 74 institutionsQ3 2022: 73 institutionsQ4 2022: 66 institutionsQ1 2023: 66 institutionsQ2 2023: 86 institutionsQ3 2023: 92 institutionsQ4 2023: 101 institutionsQ1 2024: 90 institutionsQ2 2024: 99 institutionsQ3 2024: 102 institutionsQ4 2024: 129 institutionsQ1 2025: 136 institutionsQ2 2025: 172 institutionsQ3 2025: 190 institutionsQ4 2025: 200 institutionsQ1 2026: 188 institutionsQ2 2026: 193 institutions
Value heldQ2 2023: $76.1M
Q1 2021: $107.6MQ2 2021: $78.0MQ3 2021: $55.0MQ4 2021: $59.4MQ1 2022: $73.4MQ2 2022: $49.4MQ3 2022: $31.3MQ4 2022: $47.1MQ1 2023: $44.7MQ2 2023: $76.1MQ3 2023: $66.2MQ4 2023: $70.5MQ1 2024: $73.2MQ2 2024: $74.3MQ3 2024: $154.7MQ4 2024: $186.1MQ1 2025: $144.9MQ2 2025: $420.8MQ3 2025: $501.5MQ4 2025: $488.3MQ1 2026: $279.8MQ2 2026: $345.5M
Institutions holding CRMD and their total value by quarter
QuarterHoldersValue
Q2 2026193$345.5M
Q1 2026188$279.8M
Q4 2025200$488.3M
Q3 2025190$501.5M
Q2 2025172$420.8M
Q1 2025136$144.9M
Q4 2024129$186.1M
Q3 2024102$154.7M
Q2 202499$74.3M
Q1 202490$73.2M
Q4 2023101$70.5M
Q3 202392$66.2M
Q2 202386$76.1M
Q1 202366$44.7M
Q4 202266$47.1M
Q3 202273$31.3M
Q2 202274$49.4M
Q1 202285$73.4M
Q4 202180$59.4M
Q3 202179$55.0M
Q2 202179$78.0M
Q1 202179$107.6M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding CorMedix Inc.; share changes are against Q1 2023.

Institutions holding CRMD in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
ETF Managers Group, LLC––––Not filed